Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kontafarma China Holdings Ltd ( (HK:1312) ) has shared an update.
Kontafarma China Holdings Ltd announced the appointment of three new independent non-executive directors: Dr. Tang Lai Wah, Dr. Ho Ho Ming, and Mr. Yao Xiaomin. Each appointee has confirmed their independence and lack of financial interest in the company, ensuring compliance with relevant listing rules. This move is part of the company’s efforts to strengthen its board’s independence and governance.
More about Kontafarma China Holdings Ltd
Average Trading Volume: 1,001,200
Technical Sentiment Signal: Sell
Current Market Cap: HK$161.8M
For a thorough assessment of 1312 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money